Abstract
The haemopoietic and immunostimulatory properties of recombinant human interleukin 6 (rhIL-6) might be used clinically in cancer patients. For the preclinical assessment of the safety of such a therapy, we chose the primate marmoset (Callithrix jacchus) and Wistar rats. Recombinant hIL-6 given to marmosets at doses of up to 1000 micrograms kg-1 day-1 over 4 and 9 weeks did not induce fever and was very well tolerated. Haematological alterations included a sustained two- to threefold increase of thrombocyte counts, peaking at 4 weeks, as well as an increase in neutrophils and basophils. The number of bone marrow megakaryocytes at 4 and 9 weeks was not increased, but the ploidy grade was augmented. An acute-phase protein response was observed within 24 h after the first IL-6 administration, which reached a maximum after 1 week. The acute-phase protein response was not accompanied by functional or morphological signs of hepatocellular damage. Increased immunoglobulin and soluble IL-2 receptor in the serum levels reflected systemic immunostimulation. Recombinant hIL-6 was also given to rats at 500 micrograms kg-1 day-1 s.c. for 4 weeks, where it induced a stimulation of thrombopoiesis associated with increased platelet counts withi...Continue Reading
References
Dec 1, 1992·Toxicology Letters·B RyffelL Myers
Feb 1, 1990·The Biochemical Journal·P C HeinrichT Andus
Dec 1, 1990·The Journal of Pathology·P A HallR Dover
Dec 1, 1990·Immunology Today·T HiranoT Kishimoto
Jan 1, 1990·Annual Review of Immunology·J Van Snick
Mar 1, 1990·The Journal of Experimental Medicine·J J MuléS A Rosenberg
Apr 1, 1990·The Journal of Clinical Investigation·R J HillJ Levin
Aug 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·T HiranoT Kishimoto
May 1, 1988·European Journal of Immunology·T GeigerP C Heinrich
Jan 1, 1988·Methods in Enzymology·H Baumann
Aug 11, 1989·Cell·T TagaT Kishimoto
Aug 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·T IshibashiS A Burstein
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·S SuematsuT Kishimoto
Sep 1, 1988·The Journal of Experimental Medicine·K KoikeT Akabane
Mar 1, 1988·The Journal of Experimental Medicine·M LotzD A Carson
Aug 12, 1988·Science·K YamasakiT Kishimoto
Nov 6, 1986·Nature·T HiranoA Iwamatsu
Oct 1, 1987·European Journal of Immunology·L A AardenP M Lansdorp
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·K IkebuchiM Ogawa
Citations
Jan 28, 1998·Annals of Surgery·D E RemmersI H Chaudry
Aug 2, 2000·The Journal of Physiology·T CartmellG N Luheshi
Apr 11, 2013·Human Vaccines & Immunotherapeutics·Xiao-bing ZhouBo Li